Clinical Trial Update: Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastases [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study evaluating androgen blockade therapy with or without zoledronic acid in patients with prost…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer with Bone Metastases

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Metastatic Cancer, Prostate Cancer | Phase 3 | Status: COMPLETED